D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of Non-anticoagulated Atrial Fibrillation: A Multicenter Belgian Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1368 participants.
Also called NCT04784039
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,368 participants
- Sponsor
- Registry
-
NCT04784039
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04784039. Randomized; no masking; primary purpose prevention. Start 2025-01-01 (anticipated); primary completion 2026-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of Non-anticoagulated Atrial Fibrillation: A Multicenter Belgian Study
- Acronym
- CARDDI-BEL
- Condition
- Atrial Fibrillation
- Intervention (Diagnostic test)
- Transesophageal echocardiography
- Intervention (Diagnostic test)
- D-Dimer analysis
- Lead sponsor
- AZ Sint-Jan AV
Record details
- Record id
cardio:ct-nct04784039- Content hash
080fba8b5184c8144d0000e23a2d856bc77917ca9d46c0de6f7b740f94f36b79